444 related articles for article (PubMed ID: 33172003)
1. Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study.
Davey M; Benzina S; Savoie M; Breault G; Ghosh A; Ouellette RJ
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172003
[TBL] [Abstract][Full Text] [Related]
2. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
[TBL] [Abstract][Full Text] [Related]
3. Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer.
Motamedinia P; Scott AN; Bate KL; Sadeghi N; Salazar G; Shapiro E; Ahn J; Lipsky M; Lin J; Hruby GW; Badani KK; Petrylak DP; Benson MC; Donovan MJ; Comper WD; McKiernan JM; Russo LM
PLoS One; 2016; 11(5):e0154507. PubMed ID: 27144529
[TBL] [Abstract][Full Text] [Related]
4. Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles.
Koppers-Lalic D; Hackenberg M; de Menezes R; Misovic B; Wachalska M; Geldof A; Zini N; de Reijke T; Wurdinger T; Vis A; van Moorselaar J; Pegtel M; Bijnsdorp I
Oncotarget; 2016 Apr; 7(16):22566-78. PubMed ID: 26992225
[TBL] [Abstract][Full Text] [Related]
5. Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urine.
Pellegrini KL; Patil D; Douglas KJS; Lee G; Wehrmeyer K; Torlak M; Clark J; Cooper CS; Moreno CS; Sanda MG
Prostate; 2017 Jun; 77(9):990-999. PubMed ID: 28419548
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer.
Leyten GH; Hessels D; Smit FP; Jannink SA; de Jong H; Melchers WJ; Cornel EB; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Schalken JA
Clin Cancer Res; 2015 Jul; 21(13):3061-70. PubMed ID: 25788493
[TBL] [Abstract][Full Text] [Related]
7. Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.
Mengual L; Lozano JJ; Ingelmo-Torres M; Izquierdo L; Musquera M; Ribal MJ; Alcaraz A
BMC Cancer; 2016 Feb; 16():76. PubMed ID: 26856686
[TBL] [Abstract][Full Text] [Related]
8. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
9. A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples.
Guo J; Yang J; Zhang X; Feng X; Zhang H; Chen L; Johnson H; Persson JL; Xiao K
Anticancer Res; 2018 Mar; 38(3):1471-1477. PubMed ID: 29491074
[TBL] [Abstract][Full Text] [Related]
10. Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer.
Bryzgunova OE; Zaporozhchenko IA; Lekchnov EA; Amelina EV; Konoshenko MY; Yarmoschuk SV; Pashkovskaya OA; Zheravin AA; Pak SV; Rykova EY; Laktionov PP
PLoS One; 2019; 14(4):e0215003. PubMed ID: 30970027
[TBL] [Abstract][Full Text] [Related]
11. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
13. Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4-10 ng/mL.
Zhou Y; Li Y; Li X; Jiang M
Biomed Res Int; 2017; 2017():2512536. PubMed ID: 28293631
[TBL] [Abstract][Full Text] [Related]
14. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
[TBL] [Abstract][Full Text] [Related]
15. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
[TBL] [Abstract][Full Text] [Related]
16. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
17. Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate Cancer.
Cao L; Lee CH; Ning J; Handy BC; Wagar EA; Meng QH
Arch Pathol Lab Med; 2018 Sep; 142(9):1106-1112. PubMed ID: 29547000
[TBL] [Abstract][Full Text] [Related]
18. Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer.
Woo J; Santasusagna S; Banks J; Pastor-Lopez S; Yadav K; Carceles-Cordon M; Dominguez-Andres A; Den RB; Languino LR; Pippa R; Lallas CD; Lu-Yao G; Kelly WK; Knudsen KE; Rodriguez-Bravo V; Tewari AK; Prats JM; Leiby BE; Gomella LG; Domingo-Domenech J
J Urol; 2020 Oct; 204(4):691-700. PubMed ID: 32250729
[TBL] [Abstract][Full Text] [Related]
19. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up.
Johnson H; Guo J; Zhang X; Zhang H; Simoulis A; Wu AHB; Xia T; Li F; Tan W; Johnson A; Dizeyi N; Abrahamsson PA; Kenner L; Feng X; Zou C; Xiao K; Persson JL; Chen L
BMC Med; 2020 Dec; 18(1):376. PubMed ID: 33256740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]